Citation Impact

Citing Papers

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010
2013 Standout
Control of phlebotomine sandflies
2003
Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial
2002 Standout
Leishmaniasis
2018 Standout
A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals
2003
The Predictive Validity of Naturally Acquired Delayed‐Type Hypersensitivity to Leishmanin in Resistance toLeishmania major–Associated Cutaneous Leishmaniasis
2005
Domestic dog ownership: a risk factor for human infection with Leishmania (viannia) species
2003
Sjögren's syndrome
2005 Standout
Randomized, Double-Blind Clinical Trial of Topical Imiquimod 5% with Parenteral Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis in Peru
2005
Spraying houses in the Peruvian Andes with lambda-cyhalothrin protects residents against cutaneous leishmaniasis
2000
Collaborative research into outcome measures in Sjögren's syndrome
2002
The assessment of fatigue in primary Sjögren's syndrome
2003
Endemic Transmission of Visceral Leishmaniasis in Bhutan
2012
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Using Pedometers to Increase Physical Activity and Improve Health
2007 Standout
Strategies for containing an emerging influenza pandemic in Southeast Asia
2005 StandoutNature
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial
2005
Cutaneous leishmaniasis
2007 Standout
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
2004 Standout
Cutaneous Leishmaniasis in the Peruvian Andes: Factors Associated with Variability in Clinical Symptoms, Response to Treatment, and Parasite Isolation Rate
1997
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Counseling to promote a healthy diet in adults
2003
Analysis of Granzyme B Activity as a Surrogate Marker ofLeishmania‐Specific Cell‐Mediated Cytotoxicity in Zoonotic Cutaneous Leishmaniasis
2004
Signalling mechanisms underlying subversion of the immune response by the filarial nematode secreted product ES‐62
2005
Evidence for a Major Gene Controlling Susceptibility to Tegumentary Leishmaniasis in a Recently Exposed Bolivian Population
1997
Natural history, clinical evolution, and the host-parasite interaction in New World cutaneous leishmaniasis
1996
Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention1European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/Family Medicine, European Heart Network.1,2Published simultaneously in the European Heart Journal 1998;19:1434–1503 and the Journal of Hypertension (Summary only) 1998;16(10).2
1998
Regional Variation in Out-of-Hospital Cardiac Arrest Incidence and Outcome
2008 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
2010 Standout
Measuring inconsistency in meta-analyses
2003 Standout
Human resources for health in southeast Asia: shortages, distributional challenges, and international trade in health services
2011 Standout
Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>
2001 Standout
The prolonged epidemic of anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: ‘bringing down the neighbourhood’
2003
Type 2 diabetes
2017 Standout
Developing and evaluating complex interventions: the new Medical Research Council guidance
2008 Standout
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza
1999
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
Strategies for mitigating an influenza pandemic
2006 StandoutNature
Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis
2004 Standout
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
A randomized controlled trial of insecticide-treated bednets and chaddars or top sheets, and residual spraying of interior rooms for the prevention of cutaneous leishmaniasis in Kabul, Afghanistan
2000
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial
1999 Standout
Methods in health services research: Interpreting the evidence: choosing between randomised and non-randomised studies
1999
Sjögren's syndrome associated with systemic lupus erythematosus: Clinical and laboratory profiles and comparison with primary Sjögren's syndrome
2004
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
2004 Standout
Epidemiological surveys confirm an increasing burden of cutaneous leishmaniasis in north-east Brazil
1999
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Threats to Applicability of Randomised Trials: Exclusions and Selective Participation
1999
Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm
2006 Standout
From best evidence to best practice: effective implementation of change in patients' care
2003 Standout
Epidemiologic and Immunologic Findings for the Subclinical Form ofLeishmania braziliensisInfection
2002
Improving health professionals' management and the organisation of care for overweight and obese people
2001
Influenza Viruses Resistant to the Antiviral Drug Oseltamivir: Transmission Studies in Ferrets
2004
Leishmaniasis
1999 Standout
Amantadine and rimantadine for preventing and treating influenza A in adults
2002
Guideline for Prevention of Nosocomial Pneumonia
1994
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
2005 Standout
Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes
2015
Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994
1999
Does Counseling by Clinicians Improve Physical Activity? A Summary of the Evidence for the U.S. Preventive Services Task Force
2002
EMERGING AND RESURGING VECTOR-BORNE DISEASES
1999
Epidemiology of the Leishmaniases
1995
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
2001 Standout
Interventions for providers to promote a patient-centred approach in clinical consultations
2012 Standout
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
1998 Standout
Choosing between randomised and non-randomised studies: a systematic review.
1998
Substitution of doctors by nurses in primary care
2005 Standout
Advances in leishmaniasis
2005 Standout
Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomaticLeishmania majorinfection in Tunisia
1999
In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705
2002
THE TRANSMISSION DYNAMICS OF CANINE AMERICAN CUTANEOUS LEISHMANIASIS IN HUANUCO, PERU
2003
Interventions to change health behaviours: evidence-based or evidence-inspired?
2004
Climate Warming and Disease Risks for Terrestrial and Marine Biota
2002 StandoutScience
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 Standout
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 Standout
Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries
2001
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
2012 Standout
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
The epidemiology and control of leishmaniasis in Andean countries
2000
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 Standout

Works of S Pyke being referenced

Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study
1994
Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (SS), and primary SS.
1998
Association between circulating antigen and parasite load in a model filarial system,Acanthocheilonema viteaein jirds
1990
Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity
1995
Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. The British Family Heart Study
1997
The relationship between CDC light‐trap and human‐bait catches of endophagic sandflies (Diptera: Psychodidae) in the Peruvian Andes
1995
The fall and rise of Andean cutaneous leishmaniasis: transient impact of the DDT campaign in Peru
1994
Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study
1996
Effect of non-attenders on the potential of a primary care programme to reduce cardiovascular risk in the population
1994
A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).
1996
Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine
1991
Rankless by CCL
2026